OBALON THERAPEUTICS INC·4

Jan 4, 6:31 PM ET

VandenBerg Amy 4

4 · OBALON THERAPEUTICS INC · Filed Jan 4, 2019

Insider Transaction Report

Form 4
Period: 2019-01-02
VandenBerg Amy
VP of Reg. and Clin. Affairs
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-01-02+100,000100,000 total
    Exercise: $2.30Exp: 2029-01-02Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.

Documents

1 file
  • 4
    marketforms-43643.xmlPrimary

    PRIMARY DOCUMENT